Healthcare - Biotechnology - NASDAQ - GB
$ 11.2
-3.78 %
$ 8.15 B
Market Cap
1.95
P/E
INCOME STATEMENT
125 M
REVENUE
4.24 B
OPERATING INCOME
4.23 B
NET INCOME
EFFICIENCY
Earnings Waterfall
Roivant Sciences Ltd.
| Revenue | 125 M |
| Cost Of Revenue | 15.6 M |
| Gross Profit | 109 M |
| Operating Expenses | -4.13 B |
| Operating Income | 4.24 B |
| Other Expenses | 10.8 M |
| Net Income | 4.23 B |
Income Statement
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 124.8 | 61.3 | 55.3 | 23.8 | 67.7 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 15.6 | 13.1 | 9.0 | 2.1 | 1.1 |
| Gross Profit | 109.2 | 48.2 | 46.3 | 21.7 | 66.6 |
| OPERATING INCOME | |||||
| Operating Expenses | (4 132.8) | 1 223.5 | 1 398.0 | 1 092.6 | 599.0 |
| Selling, General and Administrative Expenses | 675.0 | 600.5 | 775.0 | 259.9 | 335.8 |
| Research and Development Expenses | 501.7 | 525.2 | 483.0 | 236.6 | 263.2 |
| Operating Income | 4 242.0 | (1 175.3) | (1 351.6) | (1 070.9) | (532.4) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 34.8 | 28.0 | 7.0 | 2.8 | 7.7 |
| Total Other Income | 11.4 | (49.5) | 427.9 | 172.4 | (28.6) |
| Pre-Tax Income | 4 253.4 | (1 224.8) | (923.7) | (898.5) | (561.0) |
| NET INCOME | |||||
| Tax Provision | 22.2 | 5.2 | 0.4 | 1.7 | 7.1 |
| Net Income | 4 348.9 | (1 009.0) | (845.3) | (809.2) | 1 200.5 |
| EPS | 5.55 | 1.42 | 1.26 | 1.18 | 5.21 |